Techniki łączone oparte na spektrometrii mas we współczesnych badaniach klinicznych¹⁾

1. Dunn WB, Ellis DI: Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 2005; 24; 285-294. 2. Johnstone RAW, Rose ME: Spektrometria mas. Podręcznik dla chemików i biochemików. Warszawa: PWN 2001; s. 131, 147, 265. 3. Yang Z: Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis. J Pharm Biomed Anal 2006; 40; 516-527. 4. Mayboroda OA et al.: Amino acid profilling in urine by capillary zone electrophoresis-mass spectrometry. J Chromatogr A 2007; 1159: 149-153. 5. Kuhara T: Diagnosis of inborn errors of metabolism using filter paper urine, urease treatment, isotope dilution and gas chromatography-mass spectrometry. J Chromatogr B 2001; 758: 3-25. 6. Barshop BA: Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion 2004; 4: 521-527. 7. Hasagawa Y et al.: Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry. J Chromatogr B 2005; 823: 13-17. 8. Bowron A et al.: Increased HVA detected on organic acid analysis in a patient with Costello syndrome. J Inherit Metab Dis 2005; 28: 1155-1156. 9. Marcos J et al.: The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrom) to neurosteroid production. Steroids 2004; 69: 51-60. 10. Shackleton C et al.: Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patient with 7-dehydrosterol-Δ⁷ reductase deficiency (Smith-Lemli-Opitz syndrome). J Steroid Biochem Mol Biol 2002; 82; 225-232. 11. Ferrer I et al.: Separation and identification of plasma short-chain acylocarnitine isomers by HPLC/MS/MS for the differential diagnosis of fatty acid oxidation defects and organic acidemias. J Chromatogr B 2007; 860: 121-126. 12. Elter ML, Eichhorst J, Lehotay DC: Clinical determination of 17-hydroxyprogesterone in serum by LC-MS/MS: Comparison to Coat-A-Count(tm) RIA method. J Chromatogr B 2006; 840: 69-74. 13. Norton D et al.: High performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS) assay for chiral separation of lactic acid enantiomers in urine using a teicoplanin based stationary phase. J Chromatogr B 2007; 850: 190-198. 14. Zimmermann D et al.: Determination of volatile products of human colon cell line metabolism by GC/MS analysis. Metabolomics 2007; 3: 13-17. 15. Philips M et al.: Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis 2007; 87: 44-52. 16. McGrath LT, Patric R, Silke B: Breath isoprene in patients with heart failure. Eur J Heart Failure 2001; 3: 423-427. 17. Miwa S et al.: Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients. Diabetes Res Clin Pract 2003; 61: 81-88. 18. Haigh WG, Lee SP: Identification of oxysterols in human bile and pigment gallstones. Gastroenterology 2001; 121: 118-123. 19. Mei S et al.: Determination of urinary 8-hydroxy-2´-deoxyguanosine by two approaches-capillary electrophoresis and GC/MS: An assay for in vivo oxidative DNA damage in cancer patients. J Chromatogr B 2005; 827: 83-87. 20. Varesio E et al.: Nanoscale liquid chromatography and capillary electrophoresis coupled to electrospray mass spectrometry for the detection of amyloid-β peptide related to Alzheimer´s disease. J Chromatogr A 2002; 974: 135-142. 21. Miles DR et al.: Validation and use of three complementary analytical methods (LC-FLC, LC-MS/MS and ICP-MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues. Anal Bioanal Chem 2006; 385: 345-356. 22. Zorza G, Puozzo C: New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical of vinorelbine and its metabolites in blood, plasma, urine and faeces. J Chromatogr A 2001; 926: 11-20. 23. Pitois A et al.: Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of ¹⁰B-boronophenylalanine (¹⁰B-BPA) used in boron neutron capture therapy. Anal Bioanal Chem 2006; 384: 751-760. 24. Mauri PL et al.: New approach for the detection of BSH and its metabolites using capillary electrophoresis and electrospray ionization mass spectrometry. J Chromatogr B 2003; 788: 9-16. 25. Lausecker B, Fischer G: Determination of the enantiomeric composition of a new insulin sensitizer in plasma samples from non-clinical and clinical investigation using chiral HPLC with electrospray tandem mass spectrometric detection. J Chromatogr B 2006; 835: 40-46. 26. Juzuak N et al.: Determination of glimepiride in human plasma by LC-MS-MS. Chromatographia 2007; 66: 165-168. 27. Vaidya VV et al.: LC-MS-MS determination of olmesartan in human plasma. Chromatographia 2008; 67: 147-150. 28. Yuan B et al.: Simultaneous determination of ramipril and its active metabolite ramiprilat in human plasma by LC-MS-MS. Chromatographia 2008; 68: 533-539. 29. Yang E et al.: Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. J Pharm Biomed Anal 2004; 36: 609-615. 30. Pisarev VV: HPLC/MS determination of enalapril and enalaprilat in the blood plasma. Pharmaceutical Chemistry Journal 2005; 39: 49-52. 31. McCue BA et al.: Determination of travoprost and travoprost free acid in human plasma by electrospray HPLC//MS/MS. J Pharm Biomed Anal 2002; 28: 199-208. 32. Ming M et al.: Development and evaluation of an efficient HPLC/MS/MS method for the simultaneous determination of pseudoephedrine and cetirizine in human plasma: Application to Phase-I pharmacokinetic study. J Chromatogr B 2007; 846: 105-111. 33. Le Saux T et al.: Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry. J Chromatogr B 2008; 865: 81-90. 34. Shockcor JP et al.: Application of directly coupled LC-NMR-MS to the structural elucidation of metabolites of the HIV-1 reverse-transcriptase inhibitor BW935U83. J Chromatogr B, 2000; 748: 269-279. 35. Kilic B et al.: Simultaneous LC-MS-MS determination of zolmitriptan and its active metabolite N-Desmethylzolmitriptan in human plasma. Chromatographia 2007; 66: 129-133. 36. Song O et al.: HPLC-APCI-MS for the determination of vitamin K₁ in human plasma: Method and clinical application. J Chromatogr B 2008; 875; 541-545. 37. McClean S et al.: Determination of 1,4-benzodiazepines and their metabolites by capillary electrophoresis and high-performance liquid chromatography using ultraviolet and electrospray ionisation mass spectrometry. J Chromatogr A 1999; 838: 273-291. 38. Stulten D et al.: Isolation and characterization of a new human urinary metabolite of diclofenac applying LC-NMR-MS and high-resolution mass analyses. J Pharm Biomed Anal 2008; 47: 371-376. 39. Clarke A et al.: A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. J Neural Transm 2003; 110: 1241-1255. 40. Thuyne WV, Van Eenoo P, Delbeke FT: Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis. J Chromatogr A 2008; 1210: 193-202. 41. de Oca Porto RM et al.: Gas chromatography/mass spectrometry characterization of urinary metabolites of danazol after oral administration in human. J Chromatogr B 2006; 830; 178-183. 42. Zierau O et al.: Detection of anabolic steroid abuse using a yeast transactivation system. Steroids 2008; 73: 1143-1147. 43. Thevis M, Schanzer W: Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 2007; 388: 1351-1358. 44. Wu Y-H et al.: Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair. J Chromatogr B 2008; 870: 192-202. 45. Welch MJ, Sniegoski LT, Tai S: Two new standard reference materials for the determination of drugs of abuse in human hair. Anal Bioanal Chem 2003; 376: 1205-1211. 46. Jimenez C et al.: Stability studies of amphetamine and ephedrine derivatives in urine. J Chromatogr B 2006; 843: 84-93. 47. Villain M et al.: Ultra-rapid procedure to test for g-hydroxybutyric acid in blood and urine by gas chromatography-mass spectrometry. J Chromatogr B 2003; 792: 83-87. 48. Kamata T et al.: Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a "magic mushroom" user. Ferensic Toxicol 2006; 24: 36-40. 49. Dyne D, Cocker J, Wilson HK: A novel device for capturing breath samples for solvent analysis. Sci Total Environ 1997; 199: 83-89. 50. Kremer D, Ilgen G, Feldmann J: GC-ICP-MS determination of dimethylselenide in human breath after ingestion of ⁷⁷Se-enriched selenite: monitoring of in-vivo methylation of selenium. Annal Bioanal Chem 2005; 383: 509-515. 51. Fan Z et al.: Simultaneous determination of nicotine and its nine metabolites in human urine by LC-MS-MS. Chromatographia 2008; 68: 623-627. 52. Wahl HG et al.: Simultaneous analysis of the di(2-ethylhexyl) phthalate metabolites 2 ethylhexanoic acid, 2-ethyl-3-hydroxyhexanoic acid and 2-ethyl-3-oxohexanoic acid in urine by gas chromatography-mass spectrometry. J Chromatogr B 2001; 758: 213-219. 53. Michalke B et al.: Manganese species from human serum, cerebrospinal fluid analyzed by size exclusion chromatography-, capillary electrophoresis coupled to inductively coupled plasma mass spectrometry. J Trace Elem Med Biol 2007; 21: 4-9. 54. Tranfo G et al.: Validation of an HPLC/MS/MS method with isotopic dilution for quantitative determination of trans, trans-muconic acid in urine samples of workers exposed to low benzene concentrations. J Chromatogr B 2008; 867: 26-31. 55. Zolodz MD et al.: A GC-MS/MS method for the quantitative analysis of low levels of the tyrosine metabolites maleylacetone, succinylacetone, and the tyrosine metabolism inhibitor dichloroacetate in biological fluids and tissues. J Chromatogr B 2006; 837: 125-132.